Extraordinary Strategic Advisory Group of Experts on Immunization (SAGE) meeting on Influenza A(H1N1) vaccines 7 July 2009 CCV/CICG

, Geneva Provisional list of participants
SAGE members
Professor Jon S. Abramson (Member of H1N1 Working Group) Wake Forest University 1834 Wake Forest Road Winston-Salem 27106 NC United States of America Professor Hyam N. Bashour (Unable to attend) Professor of Epidemiology and Community Health, Deputy Dean for Scientific Affairs Department of Family and Community Medicine University of Damascus Faculty of Medicine P.O. Box 9241 Damascus Syria Professor Zulfiqar Ahmed Bhutta (Unable to attend) Head Maternal and Child Health Division The Aga Khan University P.O. Box 3500 Stadium Road Karachi 74800 Pakistan Dr Supamit Chunsuttiwat (Member of H1N1 Working Group) Senior Medical Officer Department of Disease Control Ministry of Public Health Tiwanon Road 11000 Nonthaburi Thailand Professor David Durrheim (Linked by telephone) Director of Health Protection, Hunter New England Area Health Service and Professor of Public Health Newcastle University Locked Bag 10 Wallsend 2287 NSW Australia Dr J. Peter Figueroa (Linked by telephone) Professor, Public Health, Epidemiology & AIDS, Department of Community Health & Psychiatry Faculty of Medical Sciences University of the West Indies Mona Kingston 7 Jamaica tel: 1 336 716 2512 fax: 1 336 716 9699 e-mail: jabrams@wfubmc.edu

tel: +963 11 2117403; +963 11 661832 fax: +963 11 2117404 e-mail: hbashour@scs-net.org; hyamb@scs-net.org

tel: +92 21 493 9202 fax: +92 21 493 4294 e-mail: Zulfiqar.bhutta@aku.edu

tel: +662 590 3370 fax: +662 591 8432 e-mail: schunsu@hotmail.com

tel: +61-2-492 46395 fax: +61 2 492 46048 e-mail: David.Durrheim@hnehealth.nsw.gov.au

tel: +1 876-970-3252 fax: +1 876 967 1643 e-mail: peter.figueroa10@gmail.com

Dr Xiaofeng Liang Director of National Immunization Programme China Center for Disease Control and Prevention - Ministry of Health China Center for Disease Control and Prevention 27 Nanwei Lu Beijing 100050 People's Republic of China Professor Elizabeth Miller (Unable to attend) Head Immunisation Department Health Protection Agency Centre for Infections 61 Colindale Avenue London NW9 5EQ United Kingdom of Great Britain & Northern Ireland Professor Helen Rees Professor Obstetrics & Gynaecology Reproductive Health and HIV Research Unit University of the Witwatersrand PO Box 18512 Hillbrow 2038 Johannesburg South Africa Professor Arthur Lawrence Reingold Head, Division of Epidemiology School of Public Health University of California, Berkeley 140 Warren Hall Berkeley 94720-7360 CA United States of America Professor David Salisbury (Chair of SAGE and H1N1 Working Group) Director of Immunisation Department of Health Wellington House 510, Wellington House 133-155 Waterloo Road London SE1 8UG United Kingdom of Great Britain & Northern Ireland Dr Jane Soepardi Head of Sub-Directorate of Immunization Ministry of Health and Sanitation Jalan Percetakan Negara 20 P.O. Box 223 Jakarta 10560 Indonesia Dr Oyewale Tomori Professor of Virology Redeemer's University Km 46 Lagos-Ibadan Express Road P.O. box 7914, IKEJA Lagos State Nigeria

tel: +86 10 631 76 737 fax: + 86 10 631 71 724 e-mail: liangxf@hotmail.com

tel: 44 208 327 7430 (direct) fax: 44 208 327 7404 e-mail: Liz.Miller@hpa.org.uk

tel: +27 11 358 5402 fax: +27 11 358 5301 e-mail: scornell@rhru.co.za; hrees@rhru.co.za;

tel: +1 510 642 0327 fax: +1 510 643 5163 e-mail: Reingold@uclink4.berkeley.edu; reingold@berkeley.edu

tel: +44 207 972 4377 fax: +44 207 972 3989 e-mail: david.salisbury@dh.gsi.gov.uk

tel: +62 21 754 4158 fax: +62 21 428 04 154 e-mail: janesoepardi@yahoo.com ;

tel: +234 1 793 1780 fax: e-mail: oyewaletomori@yahoo.com; tomorio@run.edu.ng

Version: 08.07.2009

2

H1N1 Working Group members
Dr Nancy J. Cox Director, of Influenza Division, National Center for Immunization & Respiratory Diseases Centers for Disease Control and Prevention National Center for Infectious Diseases 1600 Clifton Rd. NE Atlanta, GA 30333 United States of America Professor Neil Ferguson (Linked by telephone) Professor of Mathematical Biology MRC Centre for Outbreak Analysis and Modelling Imperial College St. Mary's Campus Norfolk PLace Paddington London W2 1PG United Kingdom of Great Britain & Northern Ireland Mrs Teeranart Jivapaisarnpong Director, Division of Biological Products Department of Medical Sciences Ministry of Public Health Nonthaburi 11000 Thailand Professor Paul-Henri Lambert Center for Vaccinology Centre Médical Universitaire 1 rue Michel Servet 4 Genève 1211 Switzerland Professor Joahnnes Lower President Paul-Ehrlich-Institut Paul Ehrlich Strasse 51-59 Postfach 1740 Langen 63225 Germany Dr Karen Midthun Deputy Director for Medicine Center for Biologics Evaluation and Research 1401 Rockville Pike 200N (HFM-6) Rockville MD 20892 United States of America Dr Philip Minor Head, Division of Virology (Chair ECBS) National Institute for Biological Standards and Control Blanche Lane, South Mimms Potters Bar Herts EN6 3QG United Kingdom of Great Britain & Northern Ireland tel: +1404 639 3591 fax: +1 404 639 2334 e-mail: njc1@cdc.gov

tel: +44 207 594 3296 fax: +44 207 262 3495 e-mail: neil.ferguson@imperial.ac.uk

tel: +662 965 9723 fax: +662 5915448 e-mail: teena@health.moph.go.th; jnart@dmsc.moph.go.th

tel: +41 22 379 5783 fax: +41 22 702 5801 e-mail: paul.lambert@unige.ch

tel: 496103771000 fax: 496103771240 e-mail: Loejo@pei.de

tel: +1 301 827 0372 fax: +1 301 827 0440 e-mail: karen.midthun@fda.hhs.gov

tel: +44 1707 641 312 fax: +44 1707 641 050 e-mail: Philip.Minor@nibsc.hpa.org.uk

Version: 08.07.2009

3

Professor Albert Osterhaus Head of the Department of Virology Erasmus MC, Dr Molewaterplein 50 P.O. Box 2040 Rotterdam 3000 CA Netherlands Dr Stefania Salmaso (Linked by telephone) Director Centro Nazionale di Epidemiologia CNESPS Istituto Superiore di Sanità Viale Regina Elena, 299 00161 Rome Italy Professor Peter Smith (Chair GACVS) Department of Epidemiology and Population Health London School of Hygiene and Tropical Medicine Keppel Street London WC1E 7HT United Kingdom of Great Britain & Northern Ireland

tel: +31 10 704 4066 fax: 31 10 408 9485 e-mail: a.osterhaus@erasmusmc.nl

tel: +39 06 4990 4010 (4012-4013) fax: +39 06 49904111 e-mail: salmaso@iss.it

tel: +44 207 927 2246 fax: +44 207 927 2666 e-mail: Peter.Smith@lshtm.ac.uk

TCG/TAG Chairs
Dr Ciro de Quadros Executive Vice-President (AMRO TAG Chair) Sabin Vaccine Institute 2000 Pennsylvania Avenue NW Suite 7100 Washington 20006 DC United States of America Dr Robert Hall Senior Research Fellow (WPRO TAG Chair) Monash University Department of Epidemiology and Preventive Medicine 85 Commercial Road Melbourne 3008 Victoria Australia Professor Lalitha Mendis President Sri Lanka Medical Council Emeritus Professor University of Colombo / Chairperson SEARO TAG on Immunisation University of Colombo 532/3G, Sirikotha Lane Colombo 3 Sri Lanka Dr Ali Jaffer Mohamed Advisor Health Affairs & Supervising DGHA (EMRO TAG Chair) Ministry of Health, Sultanate of Oman Ministry of Health P. O. Box 393 Muscat Oman tel: +1 202 265 6515 fax: +1 202 785 7689 e-mail: ciro.dequadros@sabin.org

tel: +61 3 9903 0555 fax: e-mail: robert.hall@med.monash.edu.au

tel: +94 11 2576907 fax: +94 11 269 8802 e-mail: sirikotha@yahoo.com

tel: +968 24 600808 fax: +968 24 691162 e-mail: dg-ha@moh.gov.om

Version: 08.07.2009

4

Professor Peter Martins Ndumbe (Unable to attend) Dean, Faculty of Health Sciences, (AFRO TFI Chair (also Chair of IVAC) University of BUEA Molyko, PO Box 63 South West Province Buea Cameroon Dr Pierre Van Damme (Unable to attend) Professor, Vaccine & Infectious Diseases Institute (EURO ETAGE Chair) WHO Collaborating Center for Control and Prevention of Viral Hepatitis University of Antwerp Centre for the Evaluation of Vaccination Universiteitsplein 1 Antwerp 2610 Belgium

tel: +237 3332 2134 / +237 3332 2813 fax: +237 3332 2813 e-mail: pndumbe@yahoo.com; pndumbe@gmail.com

tel: +32 3 820 25 38 fax: +32 3 820 26 40 e-mail: pierre.vandamme@ua.ac.be

Invited Experts
Dr Gary Grohmann FASM Director, Immunobiology & Manager of Prescription Medicines Office of Laboratories & Scientific Services Therapeutic Goods Administration P.O. Box 100 Woden ACT 2606 Australia Dr Frederick Hayden (Linked by telephone) Influenza Research Coordinator International activities-Science Funding The Wellcome Trust 215 Euston Road London NW1 2BE United Kingdom of Great Britain & Northern Ireland Dr Arnold Monto Director, The University of Michigan Bioterrorism Preparedness Initiative The University of Michigan School of Public Health 109 Observatory St. Ann Arbor 48109-2029 MI United States of America tel: 612 6 232 8490 fax: 612 6 232 8564 e-mail: gary@pathogens.com.au

tel: +44 20 7611 8256 fax: +44 207 611 7288 e-mail: f.hayden@wellcome.ac.uk

tel: +1 734 764 5453 fax: +1 734 764 3192 e-mail: asmonto@umich.edu

Observers
Dr Marguerite Baxter VP Government Affairs Novartis Vaccines & Diagnostics 701 Pennsylvania Ave NW, Suite 725 Washington, DC 20004 United States of America Ms Janis Bernat Scientific Assistant International Federation of Pharmaceutical Manufacturers and Associations 15, chemin Louis-Dunant P.O. Box 195 1211 Geneva 20 Switzerland tel: +1 202 626-0100 fax: e-mail: marguerite.baxter@novartis.com

tel: +41 22 338 3225 fax: e-mail: j.bernat@ifpma.org

Version: 08.07.2009

5

Mrs Francesca Boldrini Executive Director, Global Public Affairs EU and International Organizations Novartis Vaccines & Diagnostics WSJ 210.2.30 4002 Basel Switzerland Mr Olivier Brun Global Product Manager Crucell Berna Biotech Ltd. Rehhagstrasse 79 Bern 3018 Switzerland Dr Sonia Villaseñor Bustamante Gerente de Exportaciones y Ventas Sector Privado International Business Manager Birmerx Amores 1240 Col del Valle del Benito Juarez 03100 Mexico Dr Iza Ciglenecki Medical advisor - response to epidemics and epidemiological support Médecins Sans Frontières Switzerland 78, Rue de Lausanne CP 116 1211 Geneva Switzerland Mr Nathan Wilcox telephone linked to listen Oliver Wyman 10 South Wacker Drive, 13th Floor Chicago IL 60606 United States Dr Alfred Da Silva Executive Director Agence de Médecine préventive s/c Institut Pasteur 25-28 rue du Dr Roux 75724 Paris Cedex 15 France Dr Stephen Gardner Director Market Access Influenza GlaxoSmithKline Parc de la Noire Epine Avenue Fleming 20 Wavre 1300 Belgium

tel: +41 61 32 43 265 fax: +41 61 324 20 16 e-mail: francesca.boldrini@novartis.com

tel: +41319806559 fax: e-mail: olivier.brun@crucell.ch

tel: (52-55) 5422-2873 fax: (52-55) 5422-2881 e-mail: svillasenorb@birmex.gob.mx

Tel. +41 22 849 8930 e-mail: Iza.CIGLENECKI@geneva.msf.org

tel: +1 312 902 7915 fax: +1 312 902 7989 e-mail: Nathan.Wilcox@oliverwyman.com

tel: 33 1 53 86 89 20 fax: 33 1 53 86 89 39 e-mail: ads@aamp.org

tel: +32 2 656 92 67 fax: +32 2 656 81 27 e-mail: stephen.x.gardner@gskbio.com

Version: 08.07.2009

6

Dr Bruce Gellin Director Departement of health and Human Services 200 Independence Avenue SW Washington, DR 20201 United States Dr Jesse L. Goodman Director Center for Biologics Evaluation and Research US Food and Drug Administration (FDA) 1401 Rockville Pike, Suite 200N Rockville MD 20852-1448 United States of America Mr Toru Gotanda Deputy President Kitasato Institute Biological Research Center 6-111 Arai Kitamotoshi Saitamaken 364-0026 Japan Ms Stephanie Hardy Senior Policy Advisor - Vaccines Biologics and Genetic Therapies Directorate Health Canada Tunney's Pasture Ottawa K1A 0L2 Ontario Canada Dr Norbert Hehme Chairman, IVS International Task Force, Vice President Flu Manufacturing Strategy GSK Biologicals Zirkusstrasse 40, Dresden 01069 Germany Dr Jennifer Herz Medimmune 7 rue Sully Lyon 69006 France Ms Sissel Hodne Steen Minister Counsellor Permanent Mission of Norway to the United Nations Office & other International Organizations at Geneva 31-35 Avenue de Budé Geneva 1202 Switzerland Dr Suresh S. Jadhav Executive Director Quality Assurance & Regulatory Affairs Serum Institute of India Limited 212/2 Hadapsar Pune 411 028 India

tel: 202- 690 55 66 fax: 202-690 46 31 e-mail:bruce-gellin@hhs-gov

tel: + 1 301 827 0372 fax: + 1 301 827 0440 e-mail: jgoodman@cber.fda.gov; jesse.goodman@fda.hhs.gov

tel: +81-48 593 3957 fax: +81 48 593 3851 e-mail: tgotanda@insti.kitasato-u.ac.jp

tel: 1.613.957.8228 fax: e-mail: stephanie_hardy@hc-sc.gc.ca

tel: +49 351 546 15104 fax: +49 351 456 15321 e-mail: norbert.w.hehme@gskbio.com

tel: +33 6 16 80 47 26 fax: e-mail: herzj@medimmune.com

tel: +41229180423 fax: +41229180410 e-mail: shst@mfa.no

tel: +91 202 699 3900/26602379 fax: +91 202 699 3945/3921 e-mail: ssj@seruminstitute.com

Version: 08.07.2009

7

Dr Ryoko Krause Director Biologicals and Vaccines International Federation of Pharmaceutical Manufacturers and Associations 15, chemin Louis-Dunant P.O. Box 195 1211 Geneva 20 Switzerland Dr Cornelia Kutzer Senior Marketing Manager Global BioSecurity Baxter BioScience Baxter Hyland Immuno, Ufer Str. 15 Orth/Donau 2304 Austria Consellor Thor Erik Lindgren Permanent Mission of Norway to the United Nations Office & other International Organizations at Geneva 31-35 Avenue de Budé Geneva 1202 Switzerland Professor Pierluigi Lopalco European Centre for Disease Prevention and Control Stockholm 171 83 Sweden Dr Dorothea Matysiak-Klose Robert Koch Institut DGZ - Ring 1 13068 Berlin Germany Dr Nobuhiko Okabe Director Division of Surveillance and Information National Institute of Infectious Diseases Infectious Disease Surveillance Centre 1-23-1 Toyama Shinjuku Tokyo 162 8640 Japan Dr Bram Palache Global Scientific and Public Affairs Director Influenza Vaccines Solvay Biologicals PO Box 900 1380 DA Weesp Netherlands Professor Christian Perronne Infectious Diseases Unit Hôpital Universitaire Raymond Poincaré Garches 92380 France

tel: +41 22 338 3212 fax: +41 22 338 3299 e-mail: r.krause@ifpma.org

tel: +43 1 20100 1349 fax: +43 1 20100 5073 e-mail: cornelia_kutzer@baxter.com

tel: +41229180423 fax: +41229180410 e-mail: tel@mfa.no

tel: +46 8 586 01 212 fax: +46 8 5860 1001 e-mail: pierluigi.lopalco@ecdc.europa.eu

tel: +49 30 4547 3414 fax: +49 30 4547 3533 e-mail: matysiak-klose@rki.de

tel: +81 3 5285 1111 fax: +81 3 5285 1129 e-mail: okabenob@nih.go.jp

tel: +31 294 477542 fax: +31 294 417772 e-mail: bram.palache@solvay.com

tel: +33 1 47 10 77 58 fax: +33 1 47 10 77 67 e-mail: c.perronne@rpc.aphp.fr

Version: 08.07.2009

8

Mr Jon Pearman GAVI Manager Accelerated Vaccine Introduction (AVI) GAVI Alliance Secretariat Geneva 10 Switzerland Dr Samuel Ponce de León General Director Laboratorios de Biologicos y Reactivos de Mexico, S.A. de C.V Amores 1240 Colonia del Valle 06000 Mexico DF Mexico Dr Sai D.Prasad Project Manager – Rotavirus Vaccine Project Vice President Genome Valley Shameerpet, Hyderabad 500 078. A.P. India Dr Manjari Quintanar Subdirector of the Coordination of the National Immunization Council Centro Nacional para la Salud de la Infancia y la Adolescencia Francisco de P. Miranda No. 177 1er. piso Col. Merced Gómez Deleg. Álvaro Obregón Mexico D.F. Mexico Dr David Ryan Technical Director Vaccines, CSL Pharmaceuticals Product Development 45 Poplar Road Parkville Victoria 3052 Australia Mr Adam Sabow, Partner telephone linked to listen Oliver Wyman 10 South Wacker Drive, 13th Floor Chicago IL 60606 United States Professor Claire-Anne Siegrist Director of Pediatric Department Center for Vaccinology and Neonatal Immunology CMU 1 rue Michel-Servet, 1211 Geneva 4 Switzerland Dr Susan Tamblyn Public Health Consultant Public Health Agency in Canada Public Health Agency of Canada Tunney's Pasture PL 0602D Ottawa, Ontario K1A OK9 Canada Version: 08.07.2009

tel: +41 22 909 65 30 fax: +41 22 909 65 50 mobile: +41 79 240 48 63 e-mail:jpearman@gavialliance.org

tel: (52) 54-22-28-40 y (52) 54-22fax: (52) 54-22-28-80 y (52) 54-22e-mail: sponcedeleonr@birmex.gob.mx

tel: +91 40 2348 0567 fax: +91 40 2348 0560 e-mail: prasadsd@bharatbiotech.com

tel: fax: e-mail: mwonji@yahoo.com.mx

tel: +61 3 9389 1911 fax: + 61 3 9389 1434 e-mail: David.Ryan@cs1.com.au

tel: +1 312 902 7915 fax: +1 312 902 7989 e-mail: adam.sabow@oliverwyman.com

tel: +22 379 57 78 fax: +22 379 58 01 e-mail: Claire-Anne.Siegrist@unige.ch

tel: 6138526036 fax: e-mail: susan_tamblyn@phacaspc.gc.ca

9

Dr Russell Thirsk Novartis Vaccines and Diagnostics Inc. 350 Massachusetts Avenue MA 02139 Cambridge United Kingdom of Great Britain & Northern Ireland Mr Mayuko Toyota First Secretary Permanent Mission of Japan in Geneva 3,chemin des Fins 1218 Grand-Saconnex Genève Suisse Dr Ronald Waldman U.S. Agency for International Development (USAID) Ronald Reagan Building 1300 Pennsylvania Avenue N.W. Washington, D.C. 20523-3700 United States of America Professor Albrecht Werner European Commission SANCO C Health Threats Unit HTC 02/264 11, Rue E. Ruppert 2920 Luxembourg Ms Kine Willbergh Senior Adviser Norwegian Institute of Public Health PO Box 4404, Nydalen Oslo 0403 Norway

tel: +1 617 871 7998 fax: e-mail: Russell.Thirsk@novartis.com

tel: +41-22-717-3107 fax: +41-22-717-3774 e-mail: mayuko.toyota@ge-japan.ch

tel: fax: e-mail: rwaldman@usaid.gov

tel: 00352 4301 35290 fax: e-mail:Albrecht.WERNER@ec.europa.eu

tel: +4721076494 fax: +4721076301 e-mail: kine.willbergh@fhi.no

Observers by telephone link
Dr Atika Abelin Director, Public Affairs Director, Public Affairs (IFPMA IVS Policy member) Sanofi Pasteur 2, avenue Pont Pasteur 69367 Lyon France Dr Marguerite Baxter VP Government Affairs Novartis Vaccines & Diagnostics 701 Pennsylvania Ave NW, Suite 725 Washington, DC 20004 United States of America Mrs Francesca Boldrini Executive Director, Global Public Affairs EU and International Organizations Novartis Vaccines & Diagnostics WSJ 210.2.30 4002 Basel Switzerland tel: +33 4 37377952 fax: +33 437377202 e-mail:

tel: +1 202 626-0100 fax: e-mail: marguerite.baxter@novartis.com

tel: +41 61 32 43 265 fax: +41 61 324 20 16 e-mail: francesca.boldrini@novartis.com

Version: 08.07.2009

10

Mr John Budd Chief of Communication CEE CIS Region UNICEF (Geneva) 57 avenue de la Paix (Palais des Nations) 1211 Genève 10 Switzerland Dr Kathleen L. Coelingh Senior Director Medical & Scientific Affairs MedImmune Inc. 801 Pine Street, Apartment 25A, Seattle, 98101 WA United States of America Dr Toon Digneffe Director Governmental Affairs Baxter World Trade sa Bd de la Plaine Brussels 1050 Belgium Dr Anne Golaz Senior Health Advisor - Emergencies UNICEF 5-7 Avenue de la Paix 1211 Genève 10 Switzerland Dr Emmanuel Hanon Vice-President, Head of Influenza Vaccine Franchise GlaxoSmithKline Biologicals rue de l'institut 89 Rixensart Belgium Dr Luc Hessel Executive Director Sanofi Pasteur MSD 8 Rue Jonas Salk 69367 Lyon Cedex 07 France Dr Douglas Holtzman Senior Program Officer, Infectuous Diseases Global Health Program The Bill and Melinda Gates Foundation P.O. Box 23350 Seattle 98102 WA United States of America Dr Tomia Ikeda Deputy General Manager Vaccine R&D Department Denka Seiken Co. Ltd. 1-2-2 Minami-Honcho Gosen -shi, Niigata 959-1695 Japan

tel: +41229095429 fax: e-mail: jbudd@unicef.org

tel: +1 206 695 2823 fax: +1 650 603 3396 e-mail: coelinghk@medimmune.com

tel: +32 2 650 1672 fax: e-mail: toon_digneffe@baxter.com

tel: +977 1 4419 471 fax: +977 1 4419 471 e-mail: agolaz@unicef.org

tel: +32 10 85 3319 fax: e-mail: emmanuel.hanon@gskbio.com

tel: +33 437 28 40 70 fax: +33 437 28 44 11 e-mail: lhessel@spmsd.com

tel: (206)709-3601 fax: (206)709-3170 e-mail: Douglas.Holtzman@gatesfoundation.org

tel: +81 250 43 4111 fax: +81 250 43 4252 e-mail: tom-ikeda@denka-seiken.co.jp

Version: 08.07.2009

11

Dr Yoichiro Kino General Manager Second Research Department The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN) 1-6-1 Okubo Kumamoto, 860-8588 Japan Dr Igor Krasilnikov Chief, Department of Research Microgen State Company Kozhevnichesky proesd, 4/3 115114 Moscow Russian Federation Ms Christine Ding-Ping Liu Director Division of Acute Infectious Diseases & Immunization Centers for Disease Control Department of Health No. 6, Linshen South Road, 100 Taiwan (Chinese Taipei) Dr Osman Mansoor Public Health Physician Senior Adviser EPI (New Vaccines) UNICEF 3 United Nations Plaza New York 10017 NY United States of America Dr Kathy Neuzil Senior Clinical Adviser Program for Appropriate Technology in Health 1455 NW Leary Way Seattle 98107 5136 WA United States of America Mrs Beatrice Progida Emergency preparedness specialist Pandemic focal point UNICEF 57 avenue de la Paix (Palais des Nations) 1211 Genève 10 Switzerland Dr Regina Rabinovich Director Infectious Diseases, Global Health Program The Bill and Melinda Gates Foundation P.O. Box 23350 Seattle, WA 98107-5136 United States of America Dr David Ryan Technical Director Vaccines, CSL Pharmaceuticals Product Development 45 Poplar Road Parkville Victoria 3052 Australia Version: 08.07.2009

tel: 81 968 37 4090 fax: +81 968 37 4350 e-mail: kino-yo@kaketsuken.or.jp

tel: +007 495-790-77-73 fax: +007 495- 790-77-73 e-mail: krasilnikov@bio.ru or lobastova@bio.ru tel: +886-2-23959836 fax: +886-2-23945308 e-mail: dpliu@cdc.gov.tw

tel: 1 212 326 74 10 fax: 1 212 824 64 60 e-mail: omansoor@unicef.org

tel: +1 206 285 3500 fax: 1 206 285 6619 e-mail: kneuzil@path.org

tel: +41229095641 fax: e-mail: bprogida@unicef.org

tel: +1 206 709 3490/3579 fax: +1 206 709 3170 e-mail: regina.rabinovich@gatesfoundation.org

tel: +61 3 9389 1911 fax: + 61 3 9389 1434 e-mail: David.Ryan@cs1.com.au

12

Professor Barry D. Schoub Executive Director National Institute for Communicable Diseases Private Bag X4 Sandringham 2131 South Africa Dr R.K. Suri Senior Vice President New Initiative Panacea Biotech Ltd. B-1 Extension A-27 Mohan Co-op. Indl. Estate, Mathura Rd New Delhi India Dr Masato Tashiro Director Department of Virology III (Viral Diseases & Vaccine Control) National Institute of Infectious Diseases WHO Collaborating Centre for Reference & Research of Influenza Gakuen 4-7-1 Musashi-Murayama Tokyo 208-0011 Japan Mr Jaap Venema Global Project Director Pandemic Solvay Biologicals PO Box 900 1380 DA Weesp Netherlands Dr Richard Webby Department of Infectious Diseases 262 Danny Thomas Place Memphis TN 38105 United States of America Dr Ferenc Zimonyi Chief Executive Officer Ömninvest Vaccines Omnivest Vaccines Fö utca 7 Pilisborosjenö 2097 Hungary Dr Yong Zou Medicine Manager Sinovac Biotech Ltd No 39 Shangdi Xi Road Haidian District Beijing 100085 People's Republic of China

tel: +27 11 38 66 390 fax: +27 11 38 66 455 e-mail: barrys@nicd.ac.za

tel: +91 11 41 67 90000 Extn. 2064 fax: +91 11 4167 9027 e-mail: rksuri@panaceabiotec.com

tel: 81 42 565 2498 fax: 81 42 565 2498 e-mail: mtashiro@nih.go.jp

tel: +31 294 479537 fax: +31 294 417772 e-mail: Jaap.Venema@solvay.com

tel: +1 901 595 3014 fax: +1 901 523 2622 e-mail: Richard.Webby@stjude.org

tel: fax: +36 26 536 051 e-mail: f.zimonyi@omninvest.hu

tel: +86 10 82799340 fax: e-mail: zouyong99@126.com

Version: 08.07.2009

13

Regional Offices
Dr Déo Nshimirimana Regional Adviser for VPD Regional Office for Africa (AFRO) Vaccine Preventable Diseases Division of Prevention and Control of Communicable Diseases Boîte Postale 6 Brazzaville Congo Dr Cuauhtémoc Ruiz Matus Regional Adviser/Unit Chief of Immunization Regional Office for the Americas (AMRO/PAHO) Immunization Unit, Room 511 252, 23rd Street Washington D.C. 20037 2895 United States of America Dr Jaouad Mahjour (Unable to attend) Director, Communicable Diseases Control Regional Office for Eastern Mediterranean (EMRO) Abdul Razzak Al-Sanhouri Street P.O. Box 760 8, Nasr City Cairo 11371 Egypt Dr Rebecca Martin Targeted Diseases and Immunization Team Leader Communicable Diseases Unit (CDS) Regional Office for Europe (EURO) 8, Scherfigsvej Copenhagen 2100 Denmark tel: Ext.39203 fax: +47 241 39 501/3 e-mail: nshimirimanad@afro.who.int

tel: 5200 3945 fax: e-mail: ruizcuau@paho.org

tel: +20 222 765 250 fax: +20 222 765 414 e-mail: mahjourj@emro.who.int

tel: +45 3917 1216 fax: +45 3917 1863 e-mail: rma@euro.who.int

Headquarters Secretariat
Dr.Asamoa-Baah Deputy Director-General DGD/DGO/ODG Dr. Bruce Aylward Director Polio Eradication Initiative (POL) Dr Sylvie Briand Global Influenza Programme (GIP) Epidemic and Pandemic Alert and Response (EPR) Communicable Diseases (CDS) Mr Peter Carrasco Expanded Programme on Immunization (EPI) Immunization, Vaccines and Biologicals (IVB) Dr Sudeep Chand Public Health Advisor (IVB) Dr Thomas Cherian Coordinator Expanded Programme on Immunization (EPI) Immunization, Vaccines and Biologicals (IVB) Mr Alejandro Costa Epidemic Readiness and Interventions (ERI) Epidemic and Pandemic Alert and Response (EPR) tel: + 41 22 791 44 19 e-mail: aylwardb@who.int tel: + 41 22 791 44 19 e-mail: aylwardb@who.int tel: + 41 22 791 2372 e-mail: briands@who.int

tel: + 41 22 791 1512 e-mail: carrascop@who.int tel: +44 75000 87002 e-mail: Sudeep.Chand@dh.gsi.gov.uk tel: + 41 22 791 4460 e-mail: cheriant@who.int

tel: + 41 22 791 4965 e-mail: costaa@who.int

Version: 08.07.2009

14

Dr Philippe Duclos Senior Health Adviser/SAGE Executive Secretary Immunization Policy (ICP) Immunization, Vaccines and Biologicals (IVB) Dr Martin Friede Product Research and Development (RPD) Initiative for Vaccine Research (IVR) Immunization, Vaccines and Biologicals (IVB) Dr Florence Fuchs Laboratory Quality Systems Lyon Dr Keiji Fukuda Global Influenza Programme (GIP) Epidemic and Pandemic Alert and Response (EPR) Communicable Diseases (CDS) Dr Prakash Ghimire Epidemic and Pandemic Alert and Response (EPR) Global Influenza Programme (GIP) Dr Marie-Paule Kieny Director Initiative for Vaccine Research (IVR) Immunization, Vaccines and Biologicals (IVB) Dr Jean-Marie Okwo-Bele Director Immunization, Vaccines and Biologicals (IVB) Dr Laszlo Palkonyay Product Research and Development (RPD) Initiative for Vaccine Research (IVR) Immunization, Vaccines and Biologicals (IVB) Dr Dina Pfeifer Quality, Safety and Standards (QSS) Immunization, Vaccines and Biologicals (IVB) Dr Cathy Roth Epidemic and Pandemic Alert and Response (EPR) Biorisk Reduction for Dangerous Pathogens (BDP) Dr Niteeen Wairagkar Epidemic and Pandemic Alert and Response (EPR) Global Influenza Programme (GIP) Dr David Wood Coordinator Quality, Safety and Standards (QSS) Immunization, Vaccines and Biologicals (IVB) Dr Wenqing Zhang Epidemic and Pandemic Alert and Response (EPR) Global Influenza Programme (GIP) Dr Patrick Zuber Expanded Programme on Immunization (EPI) Immunization, Vaccines and Biologicals (IVB)

tel: + 41 22 791 4527 e-mail: duclosp@who.int

tel: 41 22 791 4398 e-mail: friedem@who.int

tel: e-mail: fuchsf@who.int tel: + 41 22 791 3871 e-mail: fukudak@who.int

tel. +41 22 791 2463 e-mail: ghimirep@who.int

tel: + 41 22 791 3591 e-mail: kienym@who.int

tel: + 41 22 791 2779 e-mail: okwobelej@who.int

tel: + 41 22 791 3488 e-mail: palkonyayl@who.int

tel: + 41 22 791 2978 e-mail: pfeiferd@who.int tel: + 41 22 791 3896 e-mail: rothc@who.int

tel: + 41 22 791 3786 e-mail: wairagkarn@who.int

tel: + 41 22 791 4050 e-mail: woodd@who.int tel: + 41 22 791 4282 e-mail: zhangw@who.int

tel: + 41 22 791 1521 e-mail: zuberp@who.int

Version: 08.07.2009

15